We demonstrate that rFVIIIFc engages with CD16, activates CD16+ NK cells, and induces NK cell-mediated cellular cytotoxicity of an anti-FVIII B-cell clone from an inhibitor-positive hemophilia A patient. Here, FCGR3A is linked to hemophilia A.